申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20210355113A1
公开(公告)日:2021-11-18
The present invention provides compounds of formula (I) wherein all of the variables are as defined herein. These compounds are inhibitors of indoleamine 2,3-dioxygenase (IDO), which may be used as medicaments for the treatment of proliferative disorders, such as cancer, viral infections and/or autoimmune diseases.